- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Apr 14, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
512 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BHC | US$8.76 | -9.6% | 14.5% | US$3.2b | US$10.33 | PE-5.4x | E123.3% | n/a | ||
CYCC | US$1.76 | -16.6% | -80.1% | US$2.3m | US$163.00 | PS5.5x | E56.6% | n/a | ||
KAN | kr1.56 | -3.9% | -52.0% | kr189.1m | kr5.00 | PB4x | E88.9% | n/a | ||
HYPE3 | R$30.05 | -3.5% | -20.5% | R$19.0b | R$42.28 | PE11.5x | E14.1% | 4.1% | ||
4974 | JP¥954.00 | -0.6% | -45.2% | JP¥116.4b | JP¥1,600.00 | PE73.1x | E24.8% | 1.8% | ||
A039200 | ₩28,350.00 | 7.0% | 16.0% | ₩1.1t | ₩46,500.00 | PS218.7x | S52.7% | n/a | ||
2183 | JP¥413.00 | 7.6% | -43.2% | JP¥8.8b | JP¥500.00 | PE13.7x | E20.6% | 3.6% | ||
688222 | CN¥11.90 | -5.7% | -43.7% | CN¥5.0b | CN¥17.80 | PE108.2x | E15.6% | 0% | ||
300357 | CN¥23.15 | 2.2% | -52.4% | CN¥11.7b | n/a | PE41.6x | E22.0% | 0.9% | ||
300294 | CN¥30.61 | 1.9% | -20.2% | CN¥15.1b | CN¥32.42 | PE65x | E29.7% | 1.0% | ||
600129 | CN¥33.06 | 4.5% | -23.6% | CN¥18.0b | CN¥52.83 | PE22.4x | E22.9% | 0.9% | ||
570 | HK$4.32 | 0.5% | 0% | HK$21.8b | HK$4.70 | PE15.6x | E12.3% | 0% | ||
1J5 | S$0.27 | -1.8% | -20.6% | S$83.4m | n/a | PE9.7x | E11.4% | 3.2% | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | ||
4015 | ر.س132.00 | 0% | n/a | ر.س9.2b | ر.س132.10 | PE31.6x | E12.5% | 1.5% | ||
ERF | €59.80 | 0.8% | -2.8% | €11.5b | €59.28 | PE44.8x | E19.7% | 0.8% | ||
PAHC | US$13.11 | 1.8% | -17.4% | US$531.0m | US$10.75 | PE35.9x | E33.2% | 3.7% | ||
AYR.A | CA$3.36 | -13.0% | 300.0% | CA$369.3m | CA$5.96 | PB0.5x | E83.3% | n/a | ||
SUPN | US$30.24 | -3.8% | -17.7% | US$1.7b | US$40.33 | PE1257.7x | E58.3% | n/a | ||
IVVD | US$2.95 | -3.6% | 156.5% | US$351.7m | US$9.38 | PB2x | E65.1% | n/a | ||
BTAI | US$2.90 | 10.3% | -86.5% | US$88.7m | US$7.42 | PS64.3x | E40.3% | n/a | ||
BAYN | €26.97 | -1.3% | -56.2% | €26.5b | €37.62 | PB0.8x | E43.7% | 0.4% | ||
JAZZ | US$110.58 | -3.9% | -24.2% | US$6.9b | US$188.11 | PE16.6x | E17.3% | n/a | ||
ELAN | US$14.35 | -7.3% | 50.3% | US$7.1b | US$17.24 | PS1.6x | E91.3% | n/a |